Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model

British Journal of Surgery

Volumn 100, Issue 6, 2013, Pages 784-793

  Zhu, Y Q ^a   Cui, W G ^a   Cheng, Y S ^a   Chang, J ^a   Chen, N W ^b   Yan, L ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; BENZALKONIUM; NANOFIBER; PACLITAXEL; ZEPHIRAMINE;

ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; CARDIA; CELL PROLIFERATION; DOG; DRUG EFFECT; DRUG ELUTING STENT; FEMALE; MALE; PATHOLOGY; RANDOMIZATION; SMOOTH MUSCLE; STENOSIS, OCCLUSION AND OBSTRUCTION; STOMACH DISEASE;

ABSORBABLE IMPLANTS; ANIMALS; ANTIMITOTIC AGENTS; BENZALKONIUM COMPOUNDS; CARDIA; CELL PROLIFERATION; CONSTRICTION, PATHOLOGIC; DOGS; DRUG-ELUTING STENTS; FEMALE; MALE; MUSCLE, SMOOTH; NANOFIBERS; PACLITAXEL; RANDOM ALLOCATION; STOMACH DISEASES;

EID: 84875861527     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9106     Document Type: Article

References (36)

1. Vakil N, Kadakia S, Eckardt VF,. Pneumatic dilation in achalasia. Endoscopy 2003; 35: 526-530.
2. Eckardt VF, Gockel I, Bernhard G,. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-633
3. Kim JH, Shin JH, Song HY,. Fluoroscopically guided balloon dilation for benign anastomotic stricture in the upper gastrointestinal tract. Korean J Radiol 2008; 9: 364-370.
4. Bakken JC, Wong Kee Song LM, de Groen PC, Baron TH,. Use of a fully covered self-expandable metal stent for the treatment of benign esophageal diseases. Gastrointest Endosc 2010; 72: 712-720.
5. Repici A, Conio M, De Angelis C, Battaglia E, Musso A, Pellicano R, et al. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc 2004; 60: 513-519.
6. Song HY, Jung HY, Park SI, Kim SB, Lee DH, Kang SG, et al. Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology 2000; 217: 551-557.
7. Petruzziello L, Costamagna G,. Stenting in esophageal strictures. Dig Dis 2002; 20: 154-166.
8. Zhu YQ, Cheng YS, Tang GY, Li MH, Zhao JG, Li F,. Comparison of temporary stent insertion with pneumatic dilation of the same diameter in the treatment of achalasia patients: a retrospective study. J Gastroenterol Hepatol 2010; 25: 499-505.
9. Zhao JG, Li YD, Cheng YS, Li MH, Chen NW, Chen WX, et al. Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience. Eur Radiol 2009; 19: 1973-1980.
10. Zhu YQ, Cheng YS, Li F, Li MH, Zhao JG, Chen NW,. Application of the newly developed stents in the treatment of benign cardia stricture: an experimental comparative study. Gastrointest Endosc 2011; 73: 329-337.
11. Zhu YQ, Cheng YS, Li MH, Zhao JG, Li F, Chen NW,. Temporary self-expanding cardia stents for the treatment of achalasia: an experimental study in dogs. Neurogastroenterol Motil 2010; 22: 1240-1247, e321-e322.
12. Weintraub WS,. The pathophysiology and burden of restenosis. Am J Cardiol 2007; 100: 3K-9K.
13. Lei L, Guo SR, Chen WL, Rong HJ, Lu F,. Stents as a platform for drug delivery. Expert Opin Drug Deliv 2011; 8: 813-831.
14. Zilberman M, Eberhart RC,. Drug-eluting bioresorbable stents for various applications. Annu Rev Biomed Eng 2006; 8: 153-180.
15. Cui WG, Zhou Y, Chang J,. Electrospun nanofibrous materials for tissue engineering and drug delivery. Sci Technol Adv Mater 2010; 11: 014108.
16. Xie C, Li X, Luo X, Yang Y, Cui W, Zou J, et al. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations. Int J Pharm 2010; 391: 55-64.
17. Kim HS, Yoo HS,. MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. J Control Release 2010; 145: 264-271.
18. Saraf A, Baggett LS, Raphael RM, Kasper FK, Mikos AG,. Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J Control Release 2010; 143: 95-103.
19. Jeon SR, Eun SH, Shim CS, Ryu CB, Kim JO, Cho JY, et al. Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study. Endoscopy 2009; 41: 449-456.
20. Machan L., Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus. Adv Drug Deliv Rev 2006; 58: 447-462.
21. Lepoittevin B, Pantoustier N, Devalckenaere M, Alexandre M, Kubies D, Calberg C, et al. Poly(Ïμ-caprolactone)/clay nanocomposites by in-situ intercalative polymerization catalyzed by dibutyltin dimethoxide. Macromolecules 2002; 35: 8385-8390
22. Cui W, Li X, Zhu X, Yu G, Zhou S, Weng J,. Investigation of drug release and matrix degradation of electrospun poly(dl -lactide) fibers with paracetanol inoculation. Biomacromolecules 2006; 7: 1623-1629.
23. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB,. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230.
24. Gaumnitz EA, Bass P, Osinski MA, Sweet MA, Singaram C,. Electrophysiological and pharmacological response of chronically denervated lower esophageal sphincter of the opossum. Gastroenterology 1995; 109: 789-799.
25. Xiang ZG, Zhang ZB, Zhu L, Zhang XR,. Establishment of achalasia model in dogs. World Chin J Digestol 2002; 10: 1275-1277.
26. Pasricha PJ, Ahmed I, Jankowski RJ, Micci MA,. Endoscopic injection of skeletal muscle-derived cells augments gut smooth muscle sphincter function: implications for a novel therapeutic approach. Gastrointest Endosc 2009; 70: 1231-1237.
27. Zou XP, Zhan XB, Li ZS, Jin ZD, Wan XJ, Wang N, et al. Research on the relationship between functional changes of fibroblasts in local esophageal tissues and re-stenosis after stenting. Chin J Dig 2003; 23: 169-172.
28. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR,. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol 1996; 16: 34-43.
29. Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, et al. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med 2003; 8: 1-7.
30. Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C,. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000; 101: 812-818.
31. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, et al.; Consensus Committee. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 2002; 106: 1867-1873.
32. Richardson WS, Willis GW, Smith JW,. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003; 17: 696-698.
33. Piotet E, Escher A, Monnier P,. Esophageal and pharyngeal strictures: report on 1862 endoscopic dilatations using the Savary-Gilliard technique. Eur Arch Otorhinolaryngol 2008; 265: 357-364.
34. Axiak SM, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, et al. Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs. Int J Nanomedicine 2011; 6: 2205-2212.
35. Seong H, An TK, Khang G, Choi SU, Lee CO, Lee HB,. BCNU loaded poly(d,l -lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Int J Pharm 2003; 251: 1-12.
36. Ritger PL, Peppas NA,. A simple equation for description of solute release. I. Fickean and non-Fickean release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23-36.